Please provide your email address to receive an email when new articles are posted on . A novel assay may help direct antibody-drug conjugate therapy through measurements of HER2 and TROP2. Most ...

(RTTNews) - Akoya Biosciences, Inc. (AKYA), Thursday announced the launch of a new multiplex immunofluorescence or mIF assay to advance antibody-drug conjugate or ADC development in breast cancer, ...

The Lunaphore COMET™ platform is a fully automated liquid handler and microscope imaging scanner capable of performing sequential, multiplex, immunofluorescent staining and imaging samples adherent to ...

Hamamatsu Photonics of Japan and Massachusetts-based Vizgen have announced a strategic partnership intended to speed up research laboratory workflows. The collaboration will in particular aim to ...

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...